Lagopharm’s team has strong experience in marketing and sales
Angiox® (bivalirudin)
Direct thrombin inhibitor. Within 2 years sales achieved 5 mln USD and MS was 75%
Cimzia® (certolizumab pegol)
RA. Initiation of first auctions in S-Pet., Moscow, Yaroslavl
Elaprase®
Hunter disease. Registration of the product in Russia in 2 month, initiation of first auctions
Tracleer® (bosentan)
Pulmonary arterial hypertension. Initiation of sales in 10 regions, increase number of patients in registry on 200 patients within 1st y
Vimpat®/Keppra®
Epilepsy. Increase regional sales on 50% within 1 y
Cordaron®, Hypothiazide®, Coronal®, Torvacard®
Collaboration with Sanofi – stop sales decline and overachieved sales target (sales over 20 M EUR) in 2017
Neo-Penotran® (miconazole, metronidazole)
Increase sales on 12% and achieved 10% MS
Gynomax® (tinidazole, tioconazole)
Successful launch in Russia
Sulidine® (nimesulide)
Successful launch in Russia